Anja heads our Life Sciences & Healthcare group in Germany. She is a specialist lawyer for intellectual property law, admitted as representative before the Unified Patent Court (UPC) and has specialized in patent law for 20 years. Anja manages and coordinates complex, multinational patent infringement proceedings and drafts infringement and nullity opinions. Further, she negotiates license as well as research and development negotiations.

 

She advises on parallel opposition and nullity proceedings before the European Patent Office, the Federal Patent Court and the Federal Supreme Court. In particular, Anja represents clients from the fields of pharmaceuticals, biotech, personalised medicine and precision medicine as well as from the chemical and medical device industries and advises on related issues of digitisation. Having spent time in Geneva, Strasbourg, Tokyo and London, Anja has intercultural competence and language skills (including English, French and Japanese).

Show full CV Hide full CV

Latest news & insights

Life sciences & healthcare

Early IP Strategy for Life Sciences Start-Ups Pays off

We explain the 5 biggest pitfalls

22 March 2024
Briefing

by Dr. Anja Lunze, LL.M. and Tobias Baus, LL.M., Dipl.-Ing.

Click here to find out more
Life sciences & healthcare

Don’t forget: Early stage IP strategy | Coffee Break Life Sciences Start-ups #2

23 February 2024
In-depth analysis

by Dr. Anja Lunze, LL.M. and Tobias Baus, LL.M., Dipl.-Ing.

Click here to find out more
UPC

Forum Shopping at the UPC

Different routes for infringement and revocation proceedings?

6 February 2024
In-depth analysis

by multiple authors

Click here to find out more
Patents & innovation

11. January 2024 – CJEU Case C 473/22: Mylan AB v Gilead and others

12 January 2024
Quick read

by Dr. Anja Lunze, LL.M. and Dr. Aurel-Damian Roscher, LL.M.

Click here to find out more

Meet me at

There are no upcoming events